
Tomorrow Biostasis
Advancing biostasis by providing high-quality cryopreservation services in the heart of Europe.
USD | 2021 | 2023 |
---|---|---|
Revenues | 0000 | 0000 |
EBITDA | 0000 | 0000 |
Profit | 0000 | 0000 |
EV | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x |
R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Tomorrow Bio is a Berlin-based biotechnology company specializing in human cryopreservation, also known as biostasis. The company provides emergency medical stabilization and long-term preservation of the human body at ultra-low temperatures (-196°C) immediately after legal death. The aim is to preserve biological functions and prevent cellular decay, allowing for the possibility of future revival when medical advancements enable the treatment of currently incurable conditions. Tomorrow Bio also manages educational content and public engagement around life extension and cryonics, seeking to normalize biostasis as a legitimate medical option. In collaboration with European Biostasis Foundation (EBF), the company offers standby, stabilization, and transport services, and stores preserved bodies in dedicated cryogenic facilities in Switzerland. Its services are primarily available via subscription-based plans that include long-term storage, standby readiness, and other support infrastructure. Tomorrow Bio serves individuals interested in extending life and future medical possibilities, positioning itself at the intersection of medicine, technology, and long-term thinking.